Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 22, 1993, Pages 2693-2698

  Selhub, Jacob ^a   Jacques, Paul F ^a   Rush, David ^a   Rosenberg, Irwin H ^a   Wilson, Peter W F ^b  

^a TUFTS UNIVERSITY   (United States)

^b Framingham ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; SYNTHETASE;

AGE; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; FEMALE; FOLIC ACID BLOOD LEVEL; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMAN; MALE; NUTRITIONAL STATUS; PYRIDOXAL PHOSPHATE; PYRIDOXINE; SUPPORT, U.S. GOV'T, NON-P.H.S.; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 0027382008     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510220049033     Document Type: Article

References (20)

1. McCully KS. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
2. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ, ed. Atherosclerotic Cardiovascular Disease Hemostasis, and Endothelial Function. New York, NY: Marcel Dekker Inc; 1992:183-236.
3. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
4. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
5. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst (e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16:1114-1119.
6. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med. 1989;114:473-501.
7. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw Hill International Book Co; 1989:693-734.
8. Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham Study. Am J Public Health. 1957;47(suppl):4-24.
9. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
10. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of pyridoxal 5'-phosphate. Clin Chem. 1983;29:642-644.
11. Tamura T, Freeberg LE, Cornwell PE. Inhibition by EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem. 1990;36: 1993.
12. Rimm ED, Giovannucci EL, Stampfer MJ, Colitz GC, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135: 1114-1126.
13. Jacques PF, Sulsky SI, Sadowski JA, Phillips JCC, Rush D, Willett WC. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr. 1993;57:182-189.
14. Willett W. Nutritional Epidemiology. New York, NY: Oxford University Press Inc; 1990:92-126.
15. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr. 1992;55 (suppl):1203S-1207S.
16. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariate Methods. 2nd ed. Boston, Mass: PWS-Kent Publishing Co; 1988.
17. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co; 1986.
18. Gartler SM, Hornug SK, Motulsky AG. Effect of chronologic age on induction of cystathionine synthase, uroporphyrinogen I synthase, and glucose-6-phosphate dehydrogenase activities in lymphocytes. Proc Natl Acad Sci U S A. 1981;78:1916-1919.
19. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and with hypertensive subjects. Atherosclerosis. 1989;79:139-146.
20. Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis. 1990;81:51-60.